Back
Arcturus Therapeutics Holdings Vs. Protalix BioTherapeutics Industry Stock Comparison
Sell
27
ARCT
Arcturus Therapeutics Holdings
Last Price:
16.94
Seasonality Move:
11.22%
Buy
79
PLX
Protalix BioTherapeutics
Last Price:
1.69
Seasonality Move:
86.81%
Sell
27
Arcturus Therapeutics Holdings (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings a Buy, Sell or Hold?
- The current Arcturus Therapeutics Holdings [ARCT] share price is $16.93. The Score for ARCT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- ARCT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
79
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.68. The Score for PLX is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ARCT Stock Price Chart
What is Arcturus Therapeutics Holdings's stock price today?
-
The Arcturus Therapeutics Holdings share price today is $16.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing selling pressure, which indicates risk of future bearish movement.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing slight selling pressure.
ARCT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.85 | Sell |
Relative Strength Index (14 RSI): | 42.47 | Sell |
Chaikin Money Flow: | -203765 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.06 - 19.42) | Sell |
Bollinger Bands (100): | (18.54 - 22.88) | Sell |
PLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 71.8 | Buy |
Chaikin Money Flow: | -100386 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.11 - 1.57) | Buy |
Bollinger Bands (100): | (0.94 - 1.3) | Buy |
ARCT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.88 | Buy |
20-day SMA: | 17.97 | Sell |
50-day SMA: | 20.09 | Sell |
200-day SMA: | 26.44 | Sell |
8-day EMA: | 17.28 | Sell |
20-day EMA: | 18.04 | Sell |
50-day EMA: | 19.44 | Sell |
200-day EMA: | 23.85 | Sell |
PLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.64 | Buy |
20-day SMA: | 1.4 | Buy |
50-day SMA: | 1.2 | Buy |
200-day SMA: | 1.19 | Buy |
8-day EMA: | 1.62 | Buy |
20-day EMA: | 1.45 | Buy |
50-day EMA: | 1.27 | Buy |
200-day EMA: | 1.24 | Buy |
Arcturus Therapeutics Holdings Earnings Growth & ARCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.91 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Arcturus Therapeutics Holdings Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Protalix BioTherapeutics Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |